Literature DB >> 18211987

A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

Chigusa Morizane1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18211987     DOI: 10.1093/jjco/hym146

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  1 in total

1.  Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.

Authors:  Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Tae Hoon Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Jong Ho Moon; Sang Heum Park; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  Oncol Lett       Date:  2012-03-08       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.